Aktis Oncology, Inc. (AKTS) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $1.1 billion, Aktis Oncology, Inc. is a small-cap company. The stock currently trades at $20.27, up 1.32% today, with a 52-week range of $16.80–$29.16.
No 10-K filings found.